Skip to main content
Top
Published in: Pituitary 6/2023

Open Access 28-10-2023 | Prolactinoma | Correction

Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?

Authors: Victoria R. van Trigt, Ingrid M. Zandbergen, Iris C. M. Pelsma, Leontine E. H. Bakker, Marco J. T. Verstegen, Wouter R. van Furth, Nienke R. Biermasz

Published in: Pituitary | Issue 6/2023

Login to get access

Excerpt

Correction to: Pituitary (2023) 26:611–621 https://doi.org/10.1007/s11102-023-01346-z
Metadata
Title
Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?
Authors
Victoria R. van Trigt
Ingrid M. Zandbergen
Iris C. M. Pelsma
Leontine E. H. Bakker
Marco J. T. Verstegen
Wouter R. van Furth
Nienke R. Biermasz
Publication date
28-10-2023
Publisher
Springer US
Keyword
Prolactinoma
Published in
Pituitary / Issue 6/2023
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-023-01358-9

Other articles of this Issue 6/2023

Pituitary 6/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine